You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

PHENOXYBENZAMINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Phenoxybenzamine Hydrochloride, and what generic alternatives are available?

Phenoxybenzamine Hydrochloride is a drug marketed by Amneal, Aurobindo Pharma, Endo Operations, Hikma, Novitium Pharma, and Rising. and is included in six NDAs.

The generic ingredient in PHENOXYBENZAMINE HYDROCHLORIDE is phenoxybenzamine hydrochloride. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenoxybenzamine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Phenoxybenzamine Hydrochloride

A generic version of PHENOXYBENZAMINE HYDROCHLORIDE was approved as phenoxybenzamine hydrochloride by ENDO OPERATIONS on January 24th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PHENOXYBENZAMINE HYDROCHLORIDE?
  • What are the global sales for PHENOXYBENZAMINE HYDROCHLORIDE?
  • What is Average Wholesale Price for PHENOXYBENZAMINE HYDROCHLORIDE?
Summary for PHENOXYBENZAMINE HYDROCHLORIDE
US Patents:0
Applicants:6
NDAs:6
Finished Product Suppliers / Packagers: 5
Raw Ingredient (Bulk) Api Vendors: 104
Clinical Trials: 7
Patent Applications: 637
What excipients (inactive ingredients) are in PHENOXYBENZAMINE HYDROCHLORIDE?PHENOXYBENZAMINE HYDROCHLORIDE excipients list
DailyMed Link:PHENOXYBENZAMINE HYDROCHLORIDE at DailyMed
Drug patent expirations by year for PHENOXYBENZAMINE HYDROCHLORIDE
Recent Clinical Trials for PHENOXYBENZAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Seoul National University HospitalPhase 4
University of California, Los AngelesPhase 3
Leiden University Medical CenterPhase 4

See all PHENOXYBENZAMINE HYDROCHLORIDE clinical trials

Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for PHENOXYBENZAMINE HYDROCHLORIDE

US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 212568-001 Oct 27, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 201050-001 Jul 16, 2012 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Aurobindo Pharma PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 215600-001 May 8, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204522-001 Jan 24, 2017 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204551-001 Jun 20, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Novitium Pharma PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 215042-001 Jul 19, 2022 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.